OFATUMUMAB

Overview

OFATUMUMAB is a Schedule H drug.
Ofatumumab is used to treat chronic lymphocytic leukemia (CLL). In some patients, ofatumumab is given with another medicine called chlorambucil. Ofatumumab is a monoclonal antibody that affects the actions of the body’s immune system. Monoclonal antibodies are made to target and destroy only certain cells in the body. This may help to protect healthy cells from damage.

Usage

OFATUMUMAB is generally used to treat: Chronic Lymphocytic Leukemia

Frequently Asked Questions

Q: Is it safe on my liver?
A: Not Safe

Q: Is it safe on my kidney?
A: Not Safe

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Not enough studies to prove Risk – Ask your Doctor

How Do I Take It?

Route of Administration: IV (Intravenous)

Precautions

  • Avoid live vaccination during the treatment period.
  • Avoid contact with people who have infections.
  • It may reduce platelet counts, avoid injury or bruising.
  • Before receiving this medication, tell your doctor or pharmacist if you are allergic to it or if you have ever had a severe reaction to it; or if you have any other allergies.
  • Before using this medication, tell your doctor or pharmacist your medical history, especially of breathing problems, liver disease, heart disease, immune system problems (such as HIV).
  • This drug may make you dizzy. Alcohol or marijuana can make you more dizzy. Do not drive, use machinery, or do anything that needs alertness until you can do it safely. Limit alcoholic beverages.
  • During pregnancy, this medication should be used only when clearly needed. Discuss the risks and benefits with your doctor.
  • It is unknown whether this drug passes into breast milk and may have undesirable effects on a nursing infant. Consult your doctor before breast-feeding.

Common Side-Effects

OFATUMUMAB : Hives, Dry Skin, Skin Rash, Black (tar) Colored Stools, Abdomen Bloating Or Fullness, Body Pain, Chills, Confusion, Cough, Dizziness, Nasal Congestion, Fainting, Body Excessive Sweating, Lightheadedness, Lower Back Pain, Nausea, Vomit, Pale Skin, Weight Gain, Shortness Of Breath, Runny Nose, Sneezing, Throat Soreness, Weakness (generalized), Weight Loss (unintentional)

Serious Side-Effects

OFATUMUMAB : Eyes Blurred Vision, Chest Pain, Rapid Heart Rate (pulse), Slow Heart Rate (pulse), Difficulty Breathing, Irregular Heartbeat

Disease Interactions

OFATUMUMAB can interfere with: Hepatitis, Bacterial Infection, Fungal Infection, Protozoal Infection, Viral Inection, Tumor Lysis Syndrome, Bone Marrow Suppression

Technical Classification

OFATUMUMAB is categorized as: CD20 MONOCLONAL ANTIBODIES / ANTINEOPLASTICS

Storage Conditions

Refrigeration (Between 2 To 8 C)

Available Alternatives

What are the other drugs with similar Ingredients?

OFATUMUMABOFATUMUMAB